Youcare Pharmaceutical Group (688658.SH) subsidiary YKYY036 injection receives NMPA and FDA clinical trial approval.
Youcare Pharmaceutical Group (688658.SH) announced that its subsidiaries Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. and Youcare Pharmaceutical Group Hangzhou Tianlong Pharmaceutical Co., Ltd. recently received the "Drug Clinical Trial Approval Notice" approved and issued by the National Medical Products Administration (NMPA) for YKYY036 injection for obesity or overweight. Meanwhile, Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. recently received a letter from the U.S. Food and Drug Administration (FDA) regarding approval of the clinical trial application for YKYY036 injection for overweight or obesity (Study May Proceed Letter, IND Number: 183361).
Youcare Pharmaceutical Group (688658.SH) announced that its subsidiaries Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. and Youcare Pharmaceutical Group Hangzhou Tianlong Pharmaceutical Co., Ltd. recently received the Drug Clinical Trial Approval Notice approved and issued by the National Medical Products Administration (NMPA), agreeing to the use of YKYY036 injection for obesity or overweight. Meanwhile, Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. recently received a letter from the U.S. Food and Drug Administration (FDA) regarding approval of the clinical trial application for YKYY036 injection for overweight or obesity (Study May Proceed Letter, IND number: 183361).
Related Articles
SUNART RETAIL (06808) Issues Profit Warning: Expects Interim Net Loss and Loss Attributable to Owners of the Company Both to Be Approximately RMB 500 Million to RMB 550 Million
Lens Technology (06613) reported a net profit attributable to shareholders of approximately RMB 1.42 billion for the first three quarters, a year-on-year decrease of 50.06%.
QUANTGROUP (02685) Signs Strategic Cooperation Agreement with Chewujie (Beijing) for Framework Procurement and Scenario Empowerment of Physical AI Shopping Guide Siasun Robot&Automation
SUNART RETAIL (06808) Issues Profit Warning: Expects Interim Net Loss and Loss Attributable to Owners of the Company Both to Be Approximately RMB 500 Million to RMB 550 Million
Lens Technology (06613) reported a net profit attributable to shareholders of approximately RMB 1.42 billion for the first three quarters, a year-on-year decrease of 50.06%.
QUANTGROUP (02685) Signs Strategic Cooperation Agreement with Chewujie (Beijing) for Framework Procurement and Scenario Empowerment of Physical AI Shopping Guide Siasun Robot&Automation
